Skip to content

Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries

Comparing Refractive and Visual Outcomes of Minimally Invasive and Traditional Glaucoma Surgeries

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03584958
Enrollment
150
Registered
2018-07-12
Start date
2018-08-01
Completion date
2023-06-30
Last updated
2022-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Ocular Hypertension

Keywords

glaucoma surgery, MIGS, minimally invasive glaucoma surgery, refractive outcomes, visual outcomes

Brief summary

The primary goal of this study is to evaluate refractive and visual outcomes in glaucoma patients who will be having either traditional glaucoma surgery or minimally invasive glaucoma surgery, also known as MIGS.

Detailed description

There is an increasing number of surgical options to lower intraocular pressure (IOP) in patients with glaucoma and ocular hypertension performed with or without concurrent cataract surgery. Today, patients undergoing glaucoma surgery have increasingly higher expectations for their postoperative visual outcomes. Therefore, it is important to understand the influence of various glaucoma surgical procedures on refractive outcomes. This information would aid in patient and surgical procedure selection, pre-operative counseling to set appropriate expectations and may help surgeons adjust their plans and techniques to improve visual outcomes. The advent of minimally invasive glaucoma surgery (MIGS) procedures further highlights the importance of studying refractive outcomes as many of these surgeries are being performed earlier in the glaucoma severity spectrum where central visual potential is still preserved. Furthermore, this class of surgeries is often performed in combination with cataract surgery. There remains a lack of data regarding refractive outcomes in patients who have had phaco-iStent, phaco-Cypass, as well as goniotomy (Kahook dual blade (KDB) gonioscopy assisted transluminal trabeculotomy), and Xen gel stent implantation with or without cataract surgery. This information would help during pre-operative patient discussions and lens selection in the context of a combined procedure.

Interventions

None listed

Sponsors

Allergan
CollaboratorINDUSTRY
The American Society of Cataract and Refractive Surgery Foundation
CollaboratorOTHER
Wills Eye
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Diagnosis of glaucoma or ocular hypertension in the study eye(s) and are consented to receive any of the following procedures: * Ab interno goniotomy surgery: Gonioscopy-assisted transluminal trabeculotomy (GATT) surgery to decrease intraocular pressure. * Gelatin stent surgery: Subconjunctival stent (Xen) surgery to decrease intraocular pressure. * Suprachoroidal stent and cataract surgery: Suprachoroidal stent (Cypass) to decrease intraocular pressure in combination with cataract surgery. * Trabeculectomy surgery: Glaucoma filtering surgery to decrease intraocular pressure. * Cataract surgery: Cataract surgery with no glaucoma procedure.

Exclusion criteria

Patients with previous corneal ectasia or history of refractive procedures; patients who cannot fixate well due to poor vision (worse than 20/200)

Design outcomes

Primary

MeasureTime frameDescription
Biometry prediction accuracyBaseline, Post-op Month 1, Post-op Month 3Difference between the target refraction and the spherical equivalent of the final refraction following surgery.

Secondary

MeasureTime frameDescription
Post-operative corneal curvatureBaseline, Post-op Month 1, Post-op Month 3Variation in corneal curvature (astigmatism) following surgery.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026